β-内酰胺类抗生素在体外和体内药理反应的时间进程。 - Suppr

Suppr

超能文献

Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.

作者信息

Gerber A U, Feller C, Brugger H P

出版信息

Eur J Clin Microbiol. 1984 Dec;3(6):592-7. doi: 10.1007/BF02013630.

DOI:10.1007/BF02013630

PMID:6098475

Abstract

摘要

相似文献

Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.

Eur J Clin Microbiol. 1984 Dec;3(6):592-7. doi: 10.1007/BF02013630.

Synergism of ceftizoxime and tobramycin for Pseudomonas aeruginosa.

J Antimicrob Chemother. 1982 Nov;10 Suppl C:57-62. doi: 10.1093/jac/10.suppl_c.57.

[Synergistic activity of isepamicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo].

Jpn J Antibiot. 1988 Nov;41(11):1591-9.

Pharmacokinetic and microbial susceptibility studies of ceftriaxone.

Eur J Clin Microbiol. 1983 Oct;2(5):501-4. doi: 10.1007/BF02013916.

[Comparative effectiveness of gentamycin and other antibiotics in experiment].

Antibiotiki. 1969 Aug;14(8):716-21.

Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.

J Chemother. 1989 Jul;1(4 Suppl):184-6.

Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.

Molecules. 2016 Jan 6;21(1):62. doi: 10.3390/molecules21010062.

In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.

Ann Clin Microbiol Antimicrob. 2016 Jun 17;15(1):39. doi: 10.1186/s12941-016-0155-z.

Clinical and laboratory studies with tobramycin.

Chemotherapy. 1974;20(4):245-56. doi: 10.1159/000221814.

Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.

Chemotherapy. 1974;20(1):45-51. doi: 10.1159/000221790.

引用本文的文献

Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.

Ann Pharmacother. 2009 Jul;43(7):1324-37. doi: 10.1345/aph.1L638. Epub 2009 Jul 7.

Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Antimicrob Agents Chemother. 2004 Feb;48(2):369-77. doi: 10.1128/AAC.48.2.369-377.2004.

In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Antimicrob Agents Chemother. 1997 Sep;41(9):2053-6. doi: 10.1128/AAC.41.9.2053.

Clinical pharmacokinetics of cefotetan.

Clin Pharmacokinet. 1994 Apr;26(4):248-58. doi: 10.2165/00003088-199426040-00002.

Pharmacokinetics of intravenous antibiotics in acutely ill elderly patients.

Eur J Clin Microbiol. 1986 Dec;5(6):629-33. doi: 10.1007/BF02013286.

Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model.

Eur J Clin Microbiol Infect Dis. 1989 Mar;8(3):233-7. doi: 10.1007/BF01965266.

Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model.

Antimicrob Agents Chemother. 1991 Sep;35(9):1905-10. doi: 10.1128/AAC.35.9.1905.

Continuous infusion of beta-lactam antibiotics.

Antimicrob Agents Chemother. 1992 Dec;36(12):2577-83. doi: 10.1128/AAC.36.12.2577.

本文引用的文献

[Experimental study of optimal dose interval in antibiotic therapy].

Schweiz Med Wochenschr. 1982 Jan 9;112(2):42-5.

Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo.

Rev Infect Dis. 1981 Jan-Feb;3(1):84-97. doi: 10.1093/clinids/3.1.84.

Penetration of antibiotics into respiratory secretions.

Rev Infect Dis. 1981 Jan-Feb;3(1):67-73. doi: 10.1093/clinids/3.1.67.

Antibiotic assays in muscle: are conventional tissue levels misleading as indicator of the antibacterial activity?

Scand J Infect Dis. 1980;12(4):307-9. doi: 10.3109/inf.1980.12.issue-4.12.

Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.

J Infect Dis. 1983 May;147(5):918-32. doi: 10.1093/infdis/147.5.918.

Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.

J Infect Dis. 1983 May;147(5):910-7. doi: 10.1093/infdis/147.5.910.

Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.

J Lab Clin Med. 1982 Nov;100(5):671-81.

Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.

J Infect Dis. 1982 Nov;146(5):691-7. doi: 10.1093/infdis/146.5.691.

Postantibiotic suppression of bacterial growth.

Rev Infect Dis. 1981 Jan-Feb;3(1):28-37. doi: 10.1093/clinids/3.1.28.

Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid.

J Infect Dis. 1974 Jan;129(1):73-8. doi: 10.1093/infdis/129.1.73.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验